I'm having a hard time understanding what you are trying to convey. It seems as though you are having a hard time getting it out. I support your choice to donate to this CEO. He very much appreciates it also. But I don't take part in that type of activity. Instead, I scout out better investments wit

Absolutely, Jward replied to his tweet. He’s always on the negative side and never posts anything positive. Oh and his reactions are always 🤦‍♂️🤷‍♂️🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣🤣

Cohen is going to have that conversation with Marcus Laun later this week - as the majority of the restricted share block is owned by Marcus.

Hope, combination therapy with DCVax-L is the answer. For years NWBO has been trying different products such as Keytruda with DCVax-L. The key here is that the “other products” need DCVax-L to work not the other way around. Approval is near!

QaaS In a word? Billions$$$$$$

In America people or parties can sue anybody for anything with zero legitimate legal claim. This particular lawsuit - 2022 Cohen was winding down his partner’s general contracting business as a result of Tennant Improvement Allowance slowdowns nationwide (landlords pay to improve properties on behal

Good! Enjoy yourself. You deserve a break.

Come on let’s be realistic. Lol.

Banger - The DOE numbers do compute, because the DOE is using actual numbers and not a best case scenario, and not just one facility.

When you using national averages one small hydrogen plant in Georgia barely moves the needle on the national average price for hydrogen.

We are on the brink of a breakout. Any real investor,,not the paid variety...will acknowledge the solid steps forward after the reorganization. Leronlimab will only continue to attract more investors. The drug is just that good. Get ready for more solid steps forward. The number of long investors is

I bought at $48 with a 5%div feeling great now lol

Enough of your Dr. Senge BS already!

They are doing it and have been doing it for years day in and day out.
It is much easier to do when volume is low and it is all done with software in high frequency trades so not really anything a real person has to do.
The software can quickly execute 1000's of trades play with bid an

Good article. The writer should keep in mind that Trump and we deplorables don't try to push morons into trying to kill Harris. (Apologies if he did. I read it quickly. Late to the OK Corral today!)

This is happening for a reason. Now is it someone that
has been shorting SHMP closing out their position or???



OTC Markets OTCPK - Delayed Quote•USD NaturalShrimp Incorporated (SHMP)
0.0070 +0.0001 (+1.45%)

I don't pay short term cap gains. I'm riding this horse for a good 2 years. Hell, Trump might tank cap gains below 13% next year.

Unless the bottom falls out from weird news, but I'm not going anywhere. Cohen can build this on a 90 day time frame for all I care.

Next

Hilarious isn't it? That's why I let him stay in there along with one or two of his minions. Just for fun. The truth doesn't need to hide.

We need solid pr with time frame to ignite
If so it's could be huge spring release here

What caused the big spike in late 22? Could it happen again! $DBMM

I have been thinking the same thought…

Question is did Timberpuppet or MTG come up with this first.




https://investorshub.advfn.com/secure/priv.aspx?r=https%3a%2f%2fsubstackcdn.com%2fimage%2ffetch%2fw_1456%2cc_limit%2cf_webp%2cq_auto%3agood%2cfl

louie, this is for YOU...
https://media.gab.com/cdn-cgi/image/width=568,quality=100,fit=scale-down/system/media_attachments/files/167/323/418/original/9598ba7db0330b32.png

Sky has mentioned many times: combination is the king.

To tackle all these tumor-associated immunosuppressive characteristics, combination is the way. IMO, NWBO has achieved the most crucial milestone in treating cancer: triggering massive and sustainable t cell infiltration into tumo

That's Missling. But biotech managers in general are necessarily an optimistic bunch, and investors know this. Missling just leans far on that spectrum. Sometimes far enough to hurt his credibility. But he only fools the foolable.

OOPs, Sorry James, they called it OxyContin,

https://www.drugs.com/drug-class/narcotic-analgesics.html

and , well, the story continues

1 Purdue
2: Is it OK to market OXI as a generic
3: can Elite get (first to file)
4 : and